Raymond W. Nims, PhD, is a biosafety consultant at RMC Pharmaceutical Solutions, Inc.
Modeling the Efficacy of HTST for Inactivating Mouse Minute Virus
The authors investigate the sufficiency of high-temperature short-time treatment in inactivate mouse minute virus contamination.
Nontuberculosis Mycobacterium Contamination of a Mammalian Cell Bioreactor Process
The authors present a case study identifying a contaminant.
USP <63> Mycoplasma Tests: A New Regulation for Mycoplasma Testing
What you need to know about USP chapter <63>.
Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells
Avoid manufacturing failures by effective viral inactivation.
Cell Line Authentication Using Isoenzyme Analysis
Strategies for accurate speciation and case studies for the detection of cell line cross-contamination using a commercial kit.